TradeLink Capital’s Boston Scientific BSX Stock Holding History

TradeLink Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,654	Closed	-$208K	–	119
2015 Q3	$208K	Buy	+12,654	New	+$216K	0.51%	81
2015 Q1	–	Sell	-15,149	Closed	-$201K	–	157
2014 Q4	$201K	Hold	15,149	–	–	0.27%	135
2014 Q3	$179K	Hold	15,149	–	–	0.29%	141
2014 Q2	$194K	Hold	15,149	–	–	0.18%	190
2014 Q1	$205K	Buy	+15,149	New	+$199K	0.3%	121

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TradeLink Capital's BSX Position: Q4 2015 in Review

TradeLink Capital sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 12,654 shares — an estimated $208K sold.

TradeLink Capital first reported a position in BSX in Q1 2014 and held it in 5 quarters. The position peaked at $208K in Q3 2015. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

TradeLink Capital reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
TradeLink Capital sold 12,654 Boston Scientific shares in Q4 2015, an estimated $208K.
TradeLink Capital first reported a position in Boston Scientific in Q1 2014 and held it in 5 quarters.
TradeLink Capital's Boston Scientific position peaked at $208K in Q3 2015.
502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on TradeLink Capital's 13F filing for Q4 2015, filed 2 Feb 2016.